comparemela.com

Latest Breaking News On - Cholangiocarcinoma foundation - Page 1 : comparemela.com

Cholangiocarcinoma Drug Pulled From Market, Other Options Still Viable

While the FDA approval of Truseltiq for FGFR2-positive cholangiocarcinoma was withdrawn, there are still other viable treatment options, an expert said.

Boston researchers make progress treating rare, aggressive cancer

Families who lost loved ones working to raise awareness about cholangiocarcinoma in the hopes of saving lives.

vimarsana © 2020. All Rights Reserved.